The Biden administration said Wednesday that a funding crunch is forcing it to divert more than $10 billion in coronavirus relief to come up with money to secure the next generation of vaccines and treatments for some high-risk Americans.
from Section Page News - Modern Healthcare https://ift.tt/NIDh6p9
